Johnson & Johnson (NYSE:JNJ)

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Over the past three decades, the unlimited investing potential of biotechnology was all about growth. Companies could grow from nothing to see untold billions of dollars selling cures and treatments ...
Read Full Story »

5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense

Johnson & Johnson (NYSE: JNJ) saw its shares get hit after earnings, but it was more than just the earnings and guidance to blame. Along with issues around ongoing talcum ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray, VMware and More

Stocks were looking for direction as earnings season gets started. The bull market is now well over 10 years old, and 2019 has seen very strong stock market gains, with ...
Read Full Story »

Why Johnson & Johnson Shareholders May Have to Ignore Earnings Looking Ahead

One company that has been a champion for investors has been Johnson & Johnson (NYSE: JNJ). The company has grown and grown over the years with sales of consumer products, ...
Read Full Story »

Johnson & Johnson Slides By With Q2 Earnings

When Johnson & Johnson (NYSE: JNJ) reported its most recent quarterly results before the markets opened on Tuesday, the pharmaceutical giant said it had $2.58 in earnings per share (EPS) ...
Read Full Story »

What to Watch When Johnson & Johnson Reports Tomorrow

Johnson & Johnson (NYSE: JNJ) is scheduled to report its most recent quarterly results before the markets open on Tuesday. The consensus estimates are calling for $2.43 in earnings per ...
Read Full Story »

Microsoft, Netflix, eBay, Johnson & Johnson and More Major Earnings Coming This Week

Now that the second-quarter earnings reporting season is just kicking off, many major companies will be sharing their results in the coming weeks. Here, 24/7 Wall St. has put together ...
Read Full Story »

Why ESG Investing May Become Problematic With Overlaps and Redundancy

The bull market is now well over 10 years old, and the major equity indexes recently hit all-time highs. This is a time when investors should be considering how they ...
Read Full Story »

Forget China, 10 Big Stocks Analysts Want You to Buy Now

The week of May 17, 2019, started out as though the China trade tariffs and tit-for-tat retaliation was going to kill the strong economy and the 10-year bull market once ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Cisco, Deere, Dillard’s, J&J, L3, Macy’s, Occidental Petroleum, SunRun, Valero and More

Stocks have continued to firm up after Monday's big sell-off as trade war tensions continue to escalate with China. Stocks were indicated to open slightly higher on Thursday as well, ...
Read Full Story »

15 Great Dividend Stocks Retirees Should Own in 2019

There are many types of investors in America. Whether you are in your twenties or retired, it is important to know what strategy is the best fit for your portfolio. ...
Read Full Story »

What Drove Johnson & Johnson in Q1

Johnson & Johnson (NYSE: JNJ) released its first-quarter financial results before the markets opened on Tuesday. The health care giant said that it had $2.10 in earnings per share (EPS) ...
Read Full Story »

What to Expect When Johnson & Johnson Reports Tuesday Morning

Johnson & Johnson (NYSE: JNJ) is scheduled to release its first-quarter financial results before the markets open on Tuesday. The consensus estimates are $2.04 in earnings per share (EPS) and ...
Read Full Story »

As Recession Fears Grow, 15 Stocks to Survive a Stock Market Correction

Friday brought on major selling in the stock market, with the Dow Jones industrials down over 400 points and the S&P 500 down almost 50 points earlier in the ...
Read Full Story »

How Much More Talc Fallout Will Johnson & Johnson Face After This $29 Million Verdict?

A California jury has awarded $29 million to a woman who claimed talcum-powder-based Johnson & Johnson (NYSE: JNJ) products caused her cancer. This ruling is the most recent defeat, out of ...
Read Full Story »